ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,263.60
      -1.68%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      79.285
      0.00%
      Bitcoin
      94,495.56
      -0.22%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Germany
      5. TG

      6. Alnylam Pharmace Dl 0001 (DUL) Quote

      Alnylam Pharmace Dl 0001

      Alnylam Pharmace Dl 0001 (DUL)

      TG
      232.40
      -0.80
      (-0.34%)
      Closed January 10 4:00PM
      Realtime Data

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      232.40
      Bid
      230.50
      Ask
      233.90
      Volume
      13
      228.70 Day's Range 228.70
      132.00 52 Week Range 280.00
      Market Cap
      29.975B
      Previous Close
      233.20
      Open
      228.70
      Last Trade
      13
      @
      228.7
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      143
      Shares Outstanding
      128,980,917
      Dividend Yield
      -
      PE Ratio
      -69.72
      Earnings Per Share (EPS)
      -3.41
      Revenue
      1.83B
      Net Profit
      -440.24M

      About Alnylam Pharmace Dl 0001

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.alnylam.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Alnylam Pharmace Dl 0001 is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker DUL. The last closing price for Alnylam Pharmace Dl 0001 was 233.20 €. Over the last year, Alnylam Pharmace Dl 0001 shares have traded in a share price range of 132.00 € to 280.00 €.

      Alnylam Pharmace Dl 0001 currently has 128,980,917 shares outstanding. The market capitalization of Alnylam Pharmace Dl 0001 is 30.08 € billion. Alnylam Pharmace Dl 0001 has a price to earnings ratio (PE ratio) of -69.72.

      Ask ADVFN Intelligence (AI)

      DUL Latest News

      More News
      No news to show yet.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      173.10559006211225.4232.4223.956230.28133333DE
      4-4-1.69204737733236.4237.8223.9355232.2001409DE
      12-41.9-15.2752460809274.3279.7217143235.34937696DE
      26-4.8-2.02360876897237.2280200.1135237.99244995DE
      525430.269058296178.4280132150196.78456442DE
      156100.3575.9939416888132.05280113.5294189.42685831DE
      260125.12116.629381059107.2828079.6957178.94424269DE

      DUL - Frequently Asked Questions (FAQ)

      What is the current Alnylam Pharmace Dl 0001 share price?
      The current share price of Alnylam Pharmace Dl 0001 is 232.40 €
      How many Alnylam Pharmace Dl 0001 shares are in issue?
      Alnylam Pharmace Dl 0001 has 128,980,917 shares in issue
      What is the market cap of Alnylam Pharmace Dl 0001?
      The market capitalisation of Alnylam Pharmace Dl 0001 is EUR 30.08B
      What is the 1 year trading range for Alnylam Pharmace Dl 0001 share price?
      Alnylam Pharmace Dl 0001 has traded in the range of 132.00 € to 280.00 € during the past year
      What is the PE ratio of Alnylam Pharmace Dl 0001?
      The price to earnings ratio of Alnylam Pharmace Dl 0001 is -69.72
      What is the cash to sales ratio of Alnylam Pharmace Dl 0001?
      The cash to sales ratio of Alnylam Pharmace Dl 0001 is 16.79
      What is the reporting currency for Alnylam Pharmace Dl 0001?
      Alnylam Pharmace Dl 0001 reports financial results in USD
      What is the latest annual turnover for Alnylam Pharmace Dl 0001?
      The latest annual turnover of Alnylam Pharmace Dl 0001 is USD 1.83B
      What is the latest annual profit for Alnylam Pharmace Dl 0001?
      The latest annual profit of Alnylam Pharmace Dl 0001 is USD -440.24M
      What is the registered address of Alnylam Pharmace Dl 0001?
      The registered address for Alnylam Pharmace Dl 0001 is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Alnylam Pharmace Dl 0001 website address?
      The website address for Alnylam Pharmace Dl 0001 is www.alnylam.com
      Which industry sector does Alnylam Pharmace Dl 0001 operate in?
      Alnylam Pharmace Dl 0001 operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      76M0Realbotix Corp
      0.416 €
      (80.87%)
      		1.54M
      LT1BVerifyMe Inc
      2.70 €
      (65.64%)
      		43.88k
      ZK7Conduit Pharmaceuticals Inc
      0.129 €
      (60.25%)
      		319.72k
      N79Blackbird Critical Metals Corp
      0.1549 €
      (52.76%)
      		1.45k
      E3O1Nexoptic Technology Corp
      0.0285 €
      (50.00%)
      		3.14k
      GR2Marvel Gold Limited
      0.001 €
      (-80.00%)
      		95.54k
      1K0IGM Biosciences Inc
      1.90 €
      (-62.00%)
      		596
      0PV2Moovly Media Inc
      0.002 €
      (-55.56%)
      		1.5k
      POTAPortofino Resources Inc
      0.0028 €
      (-46.15%)
      		35k
      0M4Mersana Therapeutics Inc
      0.7058 €
      (-44.01%)
      		144.8k
      PF8European Lithium Limited
      0.0336 €
      (2.44%)
      		3M
      D7GNel ASA
      0.2451 €
      (-3.50%)
      		2.56M
      LHADeutsche Lufthansa AG
      5.656 €
      (0.35%)
      		1.9M
      G7PAEnergy Transition Minerals Ltd
      0.046 €
      (2.22%)
      		1.81M
      RQ0DWave Quantum Inc
      5.61 €
      (-8.12%)
      		1.78M

      Discussion

      View Full Feed
      gorbec1 gorbec1 57 seconds ago
      Ok I’m no where near the fires but had a friend get evacuated and haven’t heard from him since . Let’s just take a minute to think about all who may be in danger or lost there homes .
      MCIC
      StayHumble StayHumble 1 minute ago
      💹$HCMC Heading 2Court💹StrongerCase Sufficient2Disavow $PM💹 @InsidePMI Self Reports of

      Less Combustion = No Combustion

      https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/6436df8d94fa09523deadf45/1681317773824/2023-04-12_HCMC_v_PM_Ap
      HCMC PM
      TimeIsFading TimeIsFading 2 minutes ago
      Sorry they didn't get back to you yet. At least I made it apparent to them that's it's important to address this because I just heard further communication is coming out at the beginning of next week to help clear this up 👍️

      Looks like Tahoe2468 found it on pitchbook.
      KRTL
      StayHumble StayHumble 2 minutes ago
      💹 💹wow Jury Trial Incoming wow💹 💹 💹 💹 💹 huzzah
      HCMC
      DewDiligence DewDiligence 3 minutes ago
      jbog, you're confused about ENTA's royalty obligations to OMERS. The 1.42 coefficient applied to the $200M up-front cash proceeds is a ceiling, not a floor, on ENTA's cumulative payments to OMERS:

      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171766236
      ENTA
      NoMoDo NoMoDo 3 minutes ago
      My wife asked me to work with a bunch of kids 3 evenings each week. So I am not around from about 3pm-7pm on certain days. I came back to 100 posts all about age. Absurd. Some people need to get a life and the other mods need to steer the conversation to how crappy HMBL is - as I am the only mod
      HMBL
      Whalatane Whalatane 3 minutes ago
      Well AMRN's mkt cap is now only $227m
      For a BP who is willing to run a small confirmation trial using high risk secondary prevent CAD patients in Germany ...with cooperation / buy in from the German Health dept ( please no eye rolling now ) .....make an offer $600m .
      If you really be
      AMRN
      jcromeenes jcromeenes 3 minutes ago
      I don't know if he's a Trumper or not but for the last 10+ years he's been a NOT GSE'er.
      FNMA
      thenk thenk 4 minutes ago
      January 10, 2025.

      PRs are not material. Filings and financial disclosures move the needle. Even then, no SEC audited fins? Less than ideal price action.. watch.
      AZRH
      CommonCents3 CommonCents3 4 minutes ago
      So much talk on here about the holes in the data and how we are going to need another trial.....blah.....blah.....blah

      There is ONE main reason why both the EMA and the FDA are gonna approve our drug......there are basically no side effects!!! ....and therefore no real downside to giv
      AVXL
      StayHumble StayHumble 5 minutes ago
      💹wow 💹a $5M $HCMC 💹💹BUYBACK 💹 💹 💹 wow

      -A buyback of up to $5M of $HCMC common stock.

      -A spinoff of certain HCMC assets into a new publicly traded company

      -A stock dividend to $HCMC shareholders of th
      HCMC
      georgeofthebungle georgeofthebungle 5 minutes ago
      Fingers crossed 
      AFFU
      chino98 chino98 5 minutes ago
      I'm glad I'm not apart of the missied out group 😎 I did a decent purchase last night at 2.26 and am happy with that decision. Can't wait to grab more and ride the wave 🌊. I want to hold atleast 500 I'm halfway there so far! Excited to see what the 15th and 20th hold for us! 🚀
      XRPUSD
      OMOLIVES OMOLIVES 6 minutes ago
      Sorry for the language today/other day. I shouldn't have let it get to me-my bad. Took it too personal so sorry.

      ps..I know I don't have the cleanest mouth..but that was a little much. Actually almost submitted a post with the "C" word...lol.
      StayHumble StayHumble 6 minutes ago
      💹111M+ XPERT .000001 BUYS💹insider BUYBACK Ongoing💹💹 https://ih.advfn.com/stock-market/USOTC/healthier-choices-manage-pk-HCMC/trades
      HCMC
      Guzzi62 Guzzi62 6 minutes ago
      Exactly!

      Something investor and "doc" fail to recognize!

      I wonder why? Fudsters deeply hidden in the closet likely, sowing doubt!
      AVXL
      KILLAZILLA KILLAZILLA 7 minutes ago
      NOTICE TO THE BOARD....

      THIS PATHETIC PUMPER HAS BEEN SAYING "SOON" FOR OVER 4 YEARS!!!
      WDLF
      Stonerex Stonerex 7 minutes ago
      $ UBQU

      UBQU
      krab krab 7 minutes ago
      Rick,
      Considering the number shares Ackman currently holds,
      It's just the start, Ackman FnF shares profits will $6B+, 1 year after the twins migrate to the NYSE boards. Futhermore, I believe there many other large institutions FnF shares holders besides Ackman.
      FNMA
      ChannelTrader ChannelTrader 9 minutes ago
      They only care about staying in power, nothing else.
      KILLAZILLA KILLAZILLA 10 minutes ago
      LOLOLOLOL....."fairy tales"????

      ALL TRUE!!!!

      BROKE, MAKE NO $ AND TWITTER PUMPER WAS REASON FOR POP!!!!

      THAT WILL NEVER HAPPEN AGAIN!!!
      WDLF
      Researchfyi Researchfyi 10 minutes ago
      I think they may have had two offerings without fda certification. Let’s see what impact FDA has on the general public as you say.
      LQMT
      Cpap21 Cpap21 10 minutes ago
      Well said !!
      AVXL

      Your Recent History

      TG
      DUL
      Alnylam Pharmace Dl 0001
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads